Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX

302.00

+4(+1.34%)

Updated at January 14 03:30PM

Currency In JPY

Valuation

Market Cap16.61B
Enterprise Value14.11B
P/E Ratio17.79
PEG Ratio0.17
Price/Sales Ratio2.55
Price/Book Ratio1.84
Enterprise/Revenue2.09
Enterprise/EBITDA12.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.04

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue6.29B
Revenue/Share118.25
Gross Profit3.67B
EBITDA882M
Net Income898M
Diluted EPS17.89

Balance Sheet

Total Cash3.79B
Total Cash/Share75.38
Total Debt1.02B
Total Debt/Equity0.12
Current Ratio3.53
Book Value Per Share163.98

Price History

52-Week Change-2.27
52-Week High444
52-Week Low228
Moving Average 50 Days293.06
Moving Average 200 Days285.37

Statistics

Average Volume110,211
Shares Outstanding50.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor3:1
Last Split DateMarch 30, 2020